Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Traumatic Brain Injury – Epidemiology – Epidemiology – Traumatic Brain Injury – Mature markets
Clarivate Epidemiology’s coverage of traumatic brain injury comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
Alzheimer’s Disease – Current Treatment – Treatment Algorithms: Claims Data Analysis – Neuropsychiatric Therapies in Alzheimer’s Disease (US)
In 2023, Lundbeck / Otsuka’s Rexulti became the first FDA-approved drug to treat agitation associated with Alzheimer’s disease (AD). Other novel agents are now emerging as potential treatments…
Parkinson’s Disease – Current Treatment – Treatment Algorithms: Claims Data Analysis – Parkinson’s Disease (US)
Parkinson’s disease (PD) is a progressive neurodegenerative condition that is treated chronically with prescription therapies from an array of mechanistically distinct drug classes, including…
Myasthenia Gravis – Current Treatment – Current Treatment: Physician Insights – Myasthenia Gravis (US)
Myasthenia gravis (MG) is a rare neuromuscular disorder primarily caused by autoantibodies targeting acetylcholine (ACh) receptors and therefore affecting neuromuscular synaptic transmission at the…
